With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
Christopher Sieber will not perform May 22 - 24. Betsy Wolfe will not perform May 16 at 2pm and June 7 at 2pm.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results